Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Alps Medical Breakthroughs ETF (SBIO)

Alps Medical Breakthroughs ETF (SBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ALPS Holdings
  • Assets Under Management 198,025,000
  • Market Capitalization, $K 198,025
  • Shares Outstanding, K 4,450
  • 60-Month Beta 1.53
Trade SBIO with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.02 (0.04%)
  • Most Recent Dividend 0.016 on 12/19/19
  • Management Fee 0.50%
  • Sectors:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.50 +9.60%
on 09/28/20
45.40 -2.22%
on 10/16/20
+3.73 (+9.17%)
since 09/25/20
3-Month
37.20 +19.33%
on 09/04/20
45.40 -2.22%
on 10/16/20
+3.39 (+8.27%)
since 07/24/20
52-Week
25.10 +76.85%
on 03/18/20
45.40 -2.22%
on 10/16/20
+10.27 (+30.10%)
since 10/25/19

Most Recent Stories

More News
Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

BMY : 59.67 (-0.77%)
XBI : 116.05 (-1.34%)
XPH : 45.57 (-1.77%)
BBC : 40.37 (-1.70%)
SBIO : 44.39 (-0.38%)
MYOK : 223.00 (+0.01%)
ARKG : 69.11 (-1.43%)
New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

MRNA : 70.24 (-0.41%)
ALNY : 128.67 (-2.40%)
BIO : 583.82 (+0.36%)
SBIO : 44.39 (-0.38%)
PBE : 59.16 (-0.85%)
ARKG : 69.11 (-1.43%)
Don't "Bet Against the American Economy:" ETF Areas to Win

Fed Chair Powell expressed optimism about the U.S. economic recovery over the long term. These ETF areas should benefit ahead.

IWM : 159.55 (-2.16%)
UUP : 25.13 (+0.36%)
XLY : 150.05 (-1.92%)
PKB : 36.92 (-3.68%)
PSCD : 68.44 (-1.95%)
SGDJ : 46.61 (-2.08%)
VUG : 230.30 (-1.70%)
SBIO : 44.39 (-0.38%)
SPYG : 50.57 (-1.79%)
USDU : 26.15 (+0.19%)
DGBP : 24.50 (+0.66%)
Follow Warren Buffett With 5 ETF Strategies & Tackle COVID-19

Follow Warren Buffett???s latest COVID-19-fighting tips with these ETF strategies.

XHB : 54.01 (-3.24%)
ITB : 54.48 (-3.66%)
JETS : 17.78 (-4.82%)
PKB : 36.92 (-3.68%)
IYG : 124.82 (-2.33%)
IAK : 58.24 (-2.45%)
SGDJ : 46.61 (-2.08%)
IAI : 63.94 (-2.04%)
SBIO : 44.39 (-0.38%)
IAT : 37.09 (-2.06%)
The Zacks Analyst Blog Highlights: SGDJ, PKB, SBIO and TAN

The Zacks Analyst Blog Highlights: SGDJ, PKB, SBIO and TAN

TAN : 69.63 (-2.10%)
PKB : 36.92 (-3.68%)
SGDJ : 46.61 (-2.08%)
SBIO : 44.39 (-0.38%)
Bet on "American Magic" With 4 Solid Small-Cap Sector ETFs

These small-cap sector ETFs have put a great show in the past month and are likely to fare better in the post-lockdown period.

SPY : 339.39 (-1.85%)
IWM : 159.55 (-2.16%)
TAN : 69.63 (-2.10%)
PKB : 36.92 (-3.68%)
SGDJ : 46.61 (-2.08%)
SBIO : 44.39 (-0.38%)
First-Mover Pandemic Disease Fight ETF On The Way

Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.

REGN : 585.74 (+1.02%)
GILD : 59.96 (-1.37%)
IMMU : 87.86 (+0.05%)
SBIO : 44.39 (-0.38%)
PBE : 59.16 (-0.85%)
MYOK : 223.00 (+0.01%)
IOVA : 36.97 (-1.81%)
ARKG : 69.11 (-1.43%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 59.96 (-1.37%)
IBB : 135.11 (-1.01%)
CNCR : 27.37 (-2.11%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
PTH : 142.06 (-1.26%)
IHF : 212.96 (-1.97%)
IHE : 165.95 (-1.28%)
XPH : 45.57 (-1.77%)
SBIO : 44.39 (-0.38%)
XHS : 81.44 (-1.73%)
PBE : 59.16 (-0.85%)
IDNA : 39.53 (-0.33%)
4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

DIA : 277.00 (-2.24%)
SOXX : 313.40 (-2.17%)
IEZ : 7.30 (-3.82%)
BBC : 40.37 (-1.70%)
SMH : 180.06 (-2.14%)
PXJ : 1.9650 (-3.91%)
SIL : 44.24 (-2.12%)
XSD : 134.39 (-1.91%)
SBIO : 44.39 (-0.38%)
XPH : 45.57 (-1.77%)
QQQ : 280.47 (-1.50%)
SPY : 339.39 (-1.85%)
GNOM : 18.81 (-0.37%)
SILJ : 14.22 (-3.13%)
Biotech Leading in Q4: Best ETFs & Stocks

We highlight five biotech ETFs and stocks that are leading the market in Q4.

SNY : 49.13 (-0.41%)
MRK : 78.84 (-1.24%)
RHHBY : 41.2300 (+0.49%)
NVS : 84.18 (-0.30%)
CNCR : 27.37 (-2.11%)
SBIO : 44.39 (-0.38%)
XBI : 116.05 (-1.34%)
BBC : 40.37 (-1.70%)
THOR : 67.99 (unch)
SRPT : 138.62 (+0.65%)
GBT : 56.53 (+0.30%)
VRTX : 207.15 (-2.09%)
AXSM : 68.69 (-3.77%)
CLSD : 1.3200 (-6.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200...

See More

Key Turning Points

2nd Resistance Point 45.70
1st Resistance Point 45.04
Last Price 44.39
1st Support Level 43.76
2nd Support Level 43.13

See More

52-Week High 45.40
Last Price 44.39
Fibonacci 61.8% 37.64
Fibonacci 50% 35.25
Fibonacci 38.2% 32.85
52-Week Low 25.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar